TABLE 1.
Characteristics of pancreatic ductal adenocarcinoma patients (N = 128).
| Characteristics | N | % |
|---|---|---|
| Status | ||
| Resectable | 64 | 50 |
| Locally advanced | 8 | 6.25 |
| Metastatic | 56 | 43.75 |
| Age | ||
| Mean ± SD | 64.63 ± 9.82 | |
| Median (min–max) | 65 (40–88) | |
| Gender | ||
| Female | 55 | 42.97 |
| Male | 73 | 57.03 |
| Tumor location | ||
| Head or neck or uncinate process | 64 | 50 |
| Body or tail | 64 | 50 |
| Age | ||
| Mean ± SD | 64.63 ± 9.82 | |
| Median (min–max) | 65 (40–88) | |
| ECOG | ||
| 0 | 80 | 62.5 |
| 1, 2, 3 | 48 | 37.5 |
| CEA Baseline (missing = 5) | ||
| Median (min–max) | 83.8 (<5.0–89,100) | |
| Low: CEA Baseline ≤5 | 63 | 51.22 |
| High: CEA Baseline >5 | 60 | 48.78 |
| CA19‐9 Baseline (missing = 1) | ||
| Median (min–max) | 4.8 (0.8–1090.8) | |
| Low: CA19‐9 Baseline ≤37 | 45 | 35.43 |
| High: CA19‐9 Baseline >37 | 82 | 64.57 |